LightPath Technologies, Inc. — Form 10-Q Summary
Period: The filing covers the quarter ended March 31, 2014, LightPath’s fiscal third quarter of 2014, and the nine months then ended. The request metadata says “2013 Q3,” but the filing itself reports fiscal 2014 Q3.
Business context and financial performance
LightPath manufactures optical components and assemblies, including precision molded optics and fiber-optic collimators. It is expanding production capacity in China; production at its new Zhenjiang facility began in April 2014.
| Metric | Three months ended March 31 | Nine months ended March 31 |
|---|---|---|
| Revenue | 2014: $3.006 million; 2013: $2.847 million | 2014: $8.723 million; 2013: $8.655 million |
| Gross margin | 2014: $1.466 million (49%); 2013: $1.324 million (49%) | 2014: $4.025 million (46%); 2013: $3.767 million (44%) |
| Operating income (loss) | 2014: $43,000; 2013: $56,000 | 2014: $(205,000); 2013: $4,000 |
| Net income (loss) | 2014: $(133,000), or $(0.01) per share; 2013: $217,000, or $0.02 per share | 2014: $(416,000), or $(0.03) per share; 2013: $459,000, or $0.04 per share |
Nine-month operating cash use was $128,000, compared with $66,000 in the prior-year period. Investing activities used $1.362 million, principally for production equipment. Financing provided $1.540 million, mostly from warrant exercises; cash increased $59,000 to $1.625 million. Cash was $1.143 million on May 5, 2014.
At March 31, 2014, current assets were $7.554 million and current liabilities $2.003 million. Total assets were $10.258 million, total liabilities $3.118 million, and equity $7.140 million. The company reported a $204.8 million accumulated deficit. No amounts were drawn under its Avidbank credit facility; capital lease obligations totaled approximately $13,700. The warrant liability was $1.010 million.
Changes versus the prior comparable period
- Third-quarter revenue rose 6%, attributed mainly to precision molded lenses for laser tools; unit shipments of precision molded optics rose 13%. Nine-month revenue increased 1%, with current-period product growth partly offset by a prior-year $451,000 Raytheon revenue contribution.
- Nine-month gross margin improved to 46% from 44%, while quarterly gross margin held at 49%. Management cited lower manufacturing costs and product mix, partly offset by higher wages.
- Net results deteriorated by about $350,000 for the quarter and $875,000 for the nine-month period. A key driver was the warrant fair-value adjustment: expense of $131,000 and $185,000, respectively, versus income of $223,000 and $488,000 in the prior-year periods.
- Nine-month SG&A increased $287,000 to $3.330 million, including increased stock compensation, legal expenses, taxes and fees, and commissions. New-product development expense rose $185,000 to $878,000.
- Inventory increased to $2.947 million from $1.771 million at June 30, 2013. Management said the increase in inventory days partly reflects reclassification of tooling costs from fixed assets to inventory. Net property and equipment increased to $2.663 million.
- Common shares outstanding increased to 14.293 million from 12.958 million at June 30, 2013, including shares issued upon warrant exercises.
Outlook, risks and unusual items
- Management expected revenue and operating cash flow to improve during the remainder of fiscal 2014, citing a 12-month backlog of approximately $4.69 million, increased bookings and quote activity, and expected growth in low-cost lenses and infrared products. These are expectations, not guarantees.
- Management anticipated further margin improvement from production yields, lower-cost materials and coatings, and the Zhenjiang facility. The company incurred about $26,000 of startup expense in Q3 and expected minimal facility savings in Q4.
- Management stated it believed resources were adequate for its fiscal 2014 plan and current operations in the coming year, but warned that failure to achieve positive cash flow and profitability could require additional capital. If financing were unavailable on reasonable terms, strategic alternatives could be considered.
- Risks identified include limited cash resources and financing needs, reliance on a few key customers, execution in new markets, ability to grow sales and control costs, and capacity constraints. DSO was 74 days versus 72 a year earlier; 53% of Q3 revenue shipped in the quarter’s final month, limiting time to collect receivables.
- The Avidbank facility provides up to a $1 million revolving line subject to eligible receivables and up to $1 million in equipment advances, secured by substantially all company assets and subject to financial covenants. No borrowings were outstanding at March 31, 2014.
- After quarter-end, LightPath agreed to a private placement with Pudong that could bring Pudong’s ownership to 19.9%. The initial price was $1.62 per share, subject to adjustment and a $1.40 floor; closing depended on conditions including governmental approvals. Management estimated proceeds of about $3.0 million at the initial price.
- A $1.1 million Raytheon development project had $133,530 recorded as other receivables and $120,000 in billed receivables outstanding at March 31; completion was expected by June 2014. Disclosure controls were deemed effective, and the filing reported no legal proceedings.
Important facts for investors to verify
- Whether the Pudong placement closed, its final price and share count, and the resulting dilution and ownership.
- Subsequent cash balances, operating cash flow, and access to financing, particularly given May 5 cash of $1.143 million and planned capital spending.
- Whether backlog converted to shipments and revenue, and whether growth and margin expectations—including the Zhenjiang ramp—were achieved.
- Collections on the Raytheon receivables and project completion, along with inventory levels, DSO, and any associated reserve changes.
- The continuing earnings impact and valuation assumptions for the Level 3 warrant liability, which caused substantial non-cash period-to-period earnings swings.